ArticleNuclear medicine and biology2012

Radioimmunotargeting of malignant glioma by monoclonal antibody D2C7 reactive against both wild-type and variant III mutant epidermal growth factor receptors.

Michael R Zalutsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.